11 unchanged sentences
Purchased Under
−Removed: April 1, 2024 - April 30, 2024 986 (1)
+Added: July 1, 2024 - July 31, 2024 974 (1)
— $3,849,610,303
−Removed: May 1, 2024 - May 31, 2024 1,058 (1)
+Added: August 1, 2024 - August 30, 2024 856 (1)
— $3,849,610,303
−Removed: June 1, 2024 - June 30, 2024 1,081 (1)
+Added: September 1, 2024 - September 30, 2024 902 (1)
— $3,849,610,303
1 unchanged sentence
— $3,849,610,303
−Removed: In addition to AbbVie shares repurchased on the open market under a publicly announced program, if any, these shares also included the shares purchased on the open market for the benefit of participants in the AbbVie Employee Stock Purchase Plan – 986 in April;
−Removed: 1,058 in May;
−Removed: and 1,081 in June.
+Added: In addition to AbbVie shares repurchased on the open market under a publicly announced program, if any, these shares also included the shares purchased on the open market for the benefit of participants in the AbbVie Employee Stock Purchase Plan – 974 in July;
+Added: 856 in August;
+Added: and 902 in September.
These shares do not include the shares surrendered to AbbVie to satisfy minimum tax withholding obligations in connection with the vesting or exercise of stock-based awards.
(c) Director and Officer Trading Arrangements
−Removed: During the three months ended June 30, 2024, no director or officer of the company adopted, modified or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
+Added: During the three months ended September 30, 2024, no director or officer of the company adopted, modified or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
2024 Form 10-Q |
8 unchanged sentences
101 The following financial statements and notes from the AbbVie Inc.
−Removed: Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, filed on August 7, 2024, formatted in iXBRL (Inline eXtensible Business Reporting Language):
+Added: Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, filed on November 4, 2024, formatted in iXBRL (Inline eXtensible Business Reporting Language):
(i) Condensed Consolidated Statements of Earnings;
11 unchanged sentences
Chief Financial Officer (Principal Financial Officer)
−Removed: August 7, 2024
+Added: November 4, 2024
2024 Form 10-Q |
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.